Tatsuaki Matsubara Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

12/2018	Chemerin promotes angiogenesis in vivo.
11/2012	Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: the PREMIUM Study.
6/2011	The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: results from the KING Study.
3/2011	Relation of a common variant of the adiponectin gene to serum adiponectin concentration and metabolic traits in an aged Japanese population.
3/2007	Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions integrated backscatter intravascular ultrasound study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuaki Matsubara Research Topics

Disease

16	Myocardial Infarction 10/2021 - 10/2002
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016 - 08/2008
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2004
9	Diabetic Neuropathies (Diabetic Neuropathy) 01/2021 - 06/2005
8	Periodontitis 11/2020 - 04/2012
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2018 - 03/2007
5	Acute Coronary Syndrome 01/2017 - 10/2010
5	Atherosclerosis 07/2016 - 01/2008
5	Inflammation (Inflammations) 07/2016 - 12/2009
5	Stable Angina 10/2014 - 03/2006
4	Hypertension (High Blood Pressure) 05/2022 - 02/2002
4	Heart Failure 10/2021 - 08/2005
4	ST Elevation Myocardial Infarction 06/2021 - 08/2005
3	Alveolar Bone Loss 11/2020 - 04/2012
3	Obesity 12/2018 - 03/2011
3	Neointima 12/2017 - 01/2013
3	Atherosclerotic Plaque (Atheroma) 01/2017 - 01/2008
3	Chronic Renal Insufficiency 11/2016 - 03/2012
3	Peripheral Arterial Disease 03/2013 - 07/2008
3	Insulin Resistance 11/2012 - 01/2008
3	Myocardial Ischemia (Ischemic Heart Diseases) 03/2012 - 10/2002
3	Type 2 Diabetes Mellitus (MODY) 01/2012 - 10/2008
3	Hyperlipidemias (Hyperlipidemia) 01/2009 - 11/2006
3	Angina Pectoris 05/2007 - 01/2004
2	Stroke (Strokes) 10/2021 - 08/2010
2	Hemorrhage 06/2021 - 05/2013
2	Body Weight (Weight, Body) 08/2020 - 12/2010
2	Thrombosis (Thrombus) 12/2017 - 01/2013
2	Ischemia 05/2013 - 10/2002
2	Renal Insufficiency (Renal Failure) 12/2012 - 01/2008
2	Glucose Intolerance 01/2012 - 08/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2010 - 01/2007
2	Pathologic Constriction (Stenosis) 01/2010 - 03/2007
2	Reperfusion Injury 11/2006 - 02/2006
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2021
1	Tooth Loss 01/2021
1	Edema (Dropsy) 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Diabetes Complications 01/2021
1	Bone Resorption 01/2020
1	Gout 01/2019
1	Arthritis (Polyarthritis) 01/2019

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 12/2017 - 03/2007
6	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2011
5	omega-Chloroacetophenone (Mace)IBA 10/2021 - 01/2012
5	CytokinesIBA 01/2021 - 10/2011
5	MetalsIBA 10/2013 - 03/2006
5	Sirolimus (Rapamycin)FDA Link 10/2013 - 01/2008
5	C-Reactive ProteinIBA 05/2013 - 12/2009
4	Therapeutic UsesIBA 01/2021 - 10/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2008
4	Nicorandil (SG 75)IBA 05/2007 - 08/2005
3	AdipokinesIBA 12/2018 - 12/2014
3	AdiponectinIBA 11/2012 - 03/2011
2	Amlodipine (Norvasc)FDA LinkGeneric 05/2022 - 01/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2020
2	Nerve Growth Factor (NGF)IBA 01/2021 - 01/2020
2	Nitric Oxide Synthase (NO Synthase)IBA 11/2020 - 07/2016
2	Blood Glucose (Blood Sugar)IBA 08/2020 - 02/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 07/2016
2	3-nitrotyrosineIBA 10/2017 - 04/2012
2	Nylons (Nylon)IBA 10/2017 - 04/2012
2	Messenger RNA (mRNA)IBA 03/2014 - 04/2012
2	IndicanIBA 03/2013 - 02/2013
2	Pharmaceutical PreparationsIBA 01/2013 - 08/2010
2	Indicators and Reagents (Reagents)IBA 02/2012 - 10/2008
2	Atorvastatin (Lipitor)FDA Link 01/2012 - 12/2010
2	oxidized low density lipoproteinIBA 01/2012 - 12/2010
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2012 - 11/2006
2	Proteins (Proteins, Gene)FDA Link 03/2011 - 08/2008
2	Cilostazol (Pletal)FDA LinkGeneric 01/2010 - 07/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009 - 11/2006
2	MagnesiumIBA 06/2008 - 11/2003
2	Angiotensin Receptor AntagonistsIBA 11/2007 - 11/2006
2	Antihypertensive Agents (Antihypertensives)IBA 11/2006 - 01/2004
1	ChemokinesIBA 01/2021
1	Insulin (Novolin)FDA Link 11/2020
1	Liraglutide FDA Link 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	N 30IBA 01/2020
1	Nerve Growth Factors (Neurotrophins)IBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Conditioned Culture MediaIBA 09/2019
1	Uric Acid (Urate)IBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2017

Therapy/Procedure

20	Percutaneous Coronary Intervention 06/2021 - 08/2005
13	Stents 12/2017 - 01/2008
10	Renal Dialysis (Hemodialysis) 01/2016 - 01/2007
9	Transplantation 01/2021 - 06/2005
8	Drug-Eluting Stents 12/2017 - 12/2009
7	Therapeutics 08/2020 - 02/2006
6	Ligation 11/2020 - 04/2012
4	Patient Readmission 10/2021 - 08/2005
4	Stem Cell Transplantation 01/2021 - 12/2017
2	Glycemic Control 01/2021 - 05/2013
1	Transcatheter Aortic Valve Replacement 10/2021
1	Cell Transplantation 12/2017